Table 7 Uni- and multivariate analysis to identify preoperative prognostic factors associated with overall survival in the 36 patients with LHL15 < 0.9
Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Age | 1.005 (0.95–1.07) | 0.87 | ||
Female | 0.59 (0.38–7.52) | 0.49 | ||
BMI | 0.93 (0.82–1.06) | 0.29 | ||
Lymphocyte count (/mm3) | 1.0 (1.00–1.00) | 0.69 | ||
Neutrophil count (/mm3) | 1.0 (1.00–1.00) | 0.73 | ||
Platelet count (103/µl) | 1.0 (0.97–1.03) | 0.90 | ||
Albumin (g/dl) | 0.52 (0.21–1.28) | 0.16 | ||
Total bilirubin (mg/dl) | 1.12 (0.46–2.70) | 0.81 | ||
PT-INR | 9.01 (0.18–461.3) | 0.27 | ||
Child–Pugh B | 1.86 (0.49–7.04) | 0.36 | ||
AFP (ng/ml) | 1.0 (1.00–1.00) | 0.33 | ||
DCP (mAU/ml) | 1.0 (1.00–1.00) | 0.01 | 1.0 (1.00–1.00) | 0.005 |
ICG R15 (%) | 1.03 (0.98–1.07) | 0.22 | ||
LHL15 | 7.68 (0.00–135,931) | 0.68 | ||
Tumor size (cm) | 1.11 (0.98–1.26) | 0.12 | ||
Multiple tumor | 2.82 (0.97–8.20) | 0.058 | 3.27 (1.09–9.90) | 0.035 |
Milan criteria beyond | 1.52 (0.52–4.46) | 0.45 | ||
PNI | 0.95 (0.88–1.02) | 0.15 | ||
NLR | 1.05 (0.93–1.20) | 0.44 | ||
PLR | 1.0 (1.00–1.00) | 0.59 | ||
ALBI score | 1.72 (0.72–4.13) | 0.23 | ||